Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03582670 · ClinicalTrials.gov registry record · NA

Prospective Memory Training in Parkinson Disease

A NA study of Parkinson Disease, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT03582670: Completed NA study of Parkinson Disease, sponsored by Washington University School of Medicine.

NCT03582670 is a NA study of Parkinson Disease that has completed, run by Washington University School of Medicine. The registered enrollment target is 15 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03582670, a NA study of Parkinson Disease, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The long term goal of this work is to reduce disability among people with Parkinson disease (PD) by enabling them to cope with cognitive decline so they can perform and participate in desired activities and roles. This project focuses on prospective memory, or the ability to remember to execute delayed intentions at the appropriate moment in the future. The current study tests the effects of two primary cognitive intervention approaches (process training \& strategy training) on prospective memory performance in PD. The investigators will conduct a single-blind randomized controlled trial in which individuals with mild cognitive impairment in PD (PD-MCI; N = 90) will complete pre-training assessment, randomization to training group (control, process training, strategy training), four training sessions (process and strategy training groups), and post-training assessment.

Primary Outcome

A computerized board game that simulates daily life and real-world prospective memory challenges. Each circuit represents one day in which the participant completes time-appropriate activities and makes choices about them (i.e. the ongoing activity). Each day has 8 prospective memory tasks (4 event based, 4 time based). Participants complete a practice day and then three test days, with equivalent versions counterbalanced across Pre and Post testing. The main outcome variable is the proportion o

Conditions Studied

Interventions

  • BEHAVIORAL Strategy Training
  • BEHAVIORAL Control Group
  • BEHAVIORAL Process Training

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2017-10-01
Est. Completion 2020-07-01
Phase NA

What the finished NCT03582670 record still lists

NCT03582670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 3 interventions - of which Strategy Training is the first listed.

NCT03582670 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT03582670 about?

NCT03582670 is a clinical study titled "Prospective Memory Training in Parkinson Disease". The long term goal of this work is to reduce disability among people with Parkinson disease (PD) by enabling them to cope with cognitive decline so they can perform and participate in desired activities and roles. This project focuses on prospective memory, or the ability to remember to execute dela...

What is the current status of trial NCT03582670?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-10-01. Estimated completion is 2020-07-01.

What conditions does trial NCT03582670 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT03582670?

The interventions under investigation include: Strategy Training (BEHAVIORAL), Control Group (BEHAVIORAL), Process Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03582670?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03582670 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03582670's enrollment target sits among peer trials

15 260th of 297 higher than 34 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03582670, the US trial registry maintained by the National Library of Medicine. NCT03582670 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.